JANSSEN GM26SA01 GCS 2026/ALM
€3.0M
Award value
JANSSEN CILAG
14 contracts won, worth €47.6M, from 3 public buyers.
Main sectors Medical equipment & pharmaceuticals 14
Follow this company
We email you when this company wins a new contract. Free, one click to stop.
Record
Awards by year
- 2026 10 awards €7.4M
- 2025 0 awards
- 2024 4 awards €40.2M
- €2.0M
- €20.0M
- largest, €39.7M
Each dot is one award, placed on its date and sized by its value.
Relations
Who this company works for
- Centre Hospitalier Universitaire de Toulouse 11 contracts €4,715,122
- GROUPEMENT COOPERATION SANITAIRE - UNION DES HOPITAUX POUR LES ACHATS 2 contracts €39,858,216
- Centre Hospitalier de Valenciennes 1 contract €3,006,359
Shares of the 14 contracts this company has won.
Radar
Contracts expiring soon
Contracts this company holds that end within the next two years. The specification for the replacement is usually shaped 18 to 26 months before the notice appears.
-
JANSSEN CILAG HMG24 GCS UNIHA 2024/ALM
€118,286 current contract
7 months
May 2027
-
FENTANYL FORME PERCUTANEE
€240,000 current contract
7 months
May 2027
-
GUSELKUMAB FORME INJECTABLE
€60,000 current contract
7 months
May 2027
-
JANSSEN CILAG ACP01 GCS UNIHA2024/ALM
€39.7M current contract
19 months
May 2028
Register
Contracts won
Each bar compares an award with the largest on this page, €39.7M.
ETRAVIRINE ORAL
€85,775
Award value
RILPIVIRINE ORAL
€99,254
Award value
DARUNAVIR ORAL
€40,000
Award value
ITRACONAZOLE ORAL
€120,000
Award value
EPOPROSTENOL INJ THERMOSTABLE
€817,998
Award value
BOSENTAN ORAL
€482,672
Award value
DARUNAVIR BUV
€40,000
Award value
SELEXIPAG PRESENTATION ORAL
€2.0M
Award value
BEDAQUILINE ORAL
€741,760
Award value
GUSELKUMAB FORME INJECTABLE
€60,000
Award value
JANSSEN CILAG HMG24 GCS UNIHA 2024/ALM
€118,286
Award value
JANSSEN CILAG ACP01 GCS UNIHA2024/ALM
€39.7M
Award value
FENTANYL FORME PERCUTANEE
€240,000
Award value